Hyperfine, Inc. (HYPR)
0.9307
-0.01
(-1.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Hyperfine Free Cash Flow : -27.53M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.53M |
| March 31, 2026 | -28.66M |
| December 31, 2025 | -29.13M |
| September 30, 2025 | -32.23M |
| June 30, 2025 | -35.19M |
| March 31, 2025 | -36.22M |
| December 31, 2024 | -39.15M |
| September 30, 2024 | -40.98M |
| June 30, 2024 | -41.29M |
| March 31, 2024 | -41.72M |
| Date | Value |
|---|---|
| December 31, 2023 | -42.61M |
| September 30, 2023 | -47.92M |
| June 30, 2023 | -51.90M |
| March 31, 2023 | -58.88M |
| December 31, 2022 | -72.92M |
| September 30, 2022 | -76.53M |
| June 30, 2022 | -74.57M |
| March 31, 2022 | -69.83M |
| December 31, 2021 | -49.89M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.824B |
| AngioDynamics, Inc. | -3.873M |
| Alphatec Holdings, Inc. | -5.739M |
| AtriCure, Inc. | 53.11M |
| Baxter International, Inc. | 812.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.268M |
| Cash from Investing (Quarterly) | -0.03M |
| Cash from Financing (Quarterly) | 10.78M |
| Free Cash Flow Per Share (Quarterly) | -0.0731 |
| Free Cash Flow to Equity (Quarterly) | -7.342M |
| Free Cash Flow to Firm (Quarterly) | -6.765M |
| Free Cash Flow Yield | -31.92% |